logo
Share SHARE
FONT-SIZE Plus   Neg

Simulations Plus Sees Q2 Revenues Of $2.8 Mln

Simulations Plus, Inc. (SLP), a provider of simulation software for pharmaceutical development, said Monday that it expects revenues of $2.8 million for the second quarter of fiscal 2012, up 6.4 percent from last year's revenue of $2.6 million.

The company said that approximately 15 percent of the revenues came from new software licenses and 4 percent from consulting studies.

Walt Woltosz, chief executive officer of Simulations Plus, said, "Fiscal year 2012 continues our trend of growth and profitability with a new record for any quarter in our second quarter, layering on top of our announced record first quarter revenue. We are focused on increasing our market penetration and delivering accelerating operating leverage as incremental top-line growth drives faster bottom-line increases."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology. While reporting a wider loss for the first quarter, Sears Holdings Corp. said it has decided to "aggressively evaluate" all potential alternatives for its top brands - Kenmore, Craftsman and DieHard or KCD, and the Sears Home Services or SHS businesses. Sears has retained Citigroup Global Markets and LionTree Advisors to assist in its efforts.
comments powered by Disqus
Follow RTT